After losing weight, Liraglutide could help keep it off

Embargoed until: Publicly released: 2021-05-06 07:00

International

What does this mean?

Jump to: MultimediaAttachmentsExpert Reaction

Liraglutide, a medication used to treat type 2 diabetes and obesity, could be helpful in maintaining weight loss especially when combined with an exercise program. In a paper funded by pharmaceutical company Novo Nordisk, a supplier of Liraglutide, 195 participants with obesity who lost weight during a two month low-calorie diet were assigned to one of four groups; a group using the medication in combination with an exercise program, a group given placebo medication and the exercise program, a group using Liraglutide without the exercise program and a placebo group without the exercise program (control group). After a year, the average weight loss in the combination group was a further 3.4 kilograms, while the control group gained an average 6.1 kilograms. The exercise-only group gained an average of two kilograms, and the Liraglutide-only group lost an average of 0.7 kilograms over the year.